Advertisement

Most Recent

image: Failed Drugs Expose Preclinical Blunders

Failed Drugs Expose Preclinical Blunders

By | March 30, 2012

Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.

2 Comments

image: Courts Re-Examining Gene Patents

Courts Re-Examining Gene Patents

By | March 28, 2012

The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.

2 Comments

image: Mouse Made For You

Mouse Made For You

By | March 23, 2012

Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.

4 Comments

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.

12 Comments

image: Teaching HIV/AIDS Denialism?

Teaching HIV/AIDS Denialism?

By | March 20, 2012

An Italian university is investigating whether a professor was right to teach a course denying a causal link between HIV and AIDS.

18 Comments

image: New African Bone Marrow Registry

New African Bone Marrow Registry

By | March 19, 2012

Nigeria launches its first ever bone marrow registry, which should make it easier to find matches for black people around the world.

0 Comments

image: HHMI Competition Opens

HHMI Competition Opens

By | March 16, 2012

The biomedical institute seeks up to 30 new investigators in its first nationwide search in 5 years.

0 Comments

image: Trouble at the CDC?

Trouble at the CDC?

By | March 12, 2012

Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.

4 Comments

image: High Tumor Heterogeneity Confirmed

High Tumor Heterogeneity Confirmed

By | March 9, 2012

One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.

2 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Cell Sciences
Cell Sciences
Advertisement
Life Technologies